Trial
NCT04030052
Emicizumab PUPs and Nuwiq ITI Study
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
Genentech, Inc.
Condition
Hemophilia A
Intervention
Nuwiq (low dose protocol)
Why stopped
The Emi PUPs and Nuwiq ITI study has been closed due to slow enrollment and study site startup.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-05